Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
Circulation Reports · 10.03.2023 · 5 (3) · 80-89
DOI: 10.1253/circrep.cr-22-0076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Reports, erschienen am 10.03.2023. Verfasst von Michihiro Suwa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hokusetsu General Hospital Takatsuki Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hokusetsu General Hospital Takatsuki Japan.
Zitieren
APA
Suwa, M., Nohara, Y., Morii, I., & Kino, M. (2023). Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing. Circulation Reports, 5(3), 80-89. https://doi.org/10.1253/circrep.cr-22-0076
Vancouver
Suwa M, Nohara Y, Morii I, Kino M. Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing. Circulation Reports. 2023;5(3):80-89. doi:10.1253/circrep.cr-22-0076
BibTeX
@article{Suwa2023,
author = {Suwa, Michihiro and Nohara, Yuki and Morii, Isao and Kino, Masaya},
title = {Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing},
journal = {Circulation Reports},
year = {2023},
volume = {5},
number = {3},
pages = {80--89},
doi = {10.1253/circrep.cr-22-0076}
}
EUVIMED